Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
12:00 AM - DEVICE TALKS
9
11
12
13
14
16
18
19
20
21
22
23
24
26
27
28
29
30
31
1
2
3
4
DEVICE TALKS
DEVICE TALKS BOSTON 2018: BIGGER AND BETTER THAN EVER! Join us Oct. 8-10 for the 7th annual DeviceTalks Boston, back in the city where it [...]
6th Annual HealthIMPACT Midwest
2018-10-10    
All Day
REV1 VENTURES COLUMBUS, OH The Provider-Patient Experience Summit - Disrupting Delivery without Disrupting Care HealthIMPACT Midwest is focused on technologies impacting clinician satisfaction and performance. [...]
15 Oct
2018-10-15 - 2018-10-16    
All Day
Conference Series Ltd invites all the participants from all over the world to attend “3rd International Conference on Environmental Health” during October 15-16, 2018 in Warsaw, Poland which includes prompt keynote [...]
17 Oct
2018-10-17 - 2018-10-19    
7:00 am - 6:00 pm
BALANCING TECHNOLOGY AND THE HUMAN ELEMENT In an era when digital technologies enable individuals to track health statistics such as daily activity and vital signs, [...]
Epigenetics Congress 2018
2018-10-25 - 2018-10-26    
All Day
Conference: 5th World Congress on Epigenetics and Chromosome Date: October 25-26, 2018 Place: Istanbul, Turkey Email: epigeneticscongress@gmail.com About Conference: Epigenetics congress 2018 invites all the [...]
Events on 2018-10-08
DEVICE TALKS
8 Oct 18
425 Summer Street
Events on 2018-10-10
Events on 2018-10-17
17 Oct
Events on 2018-10-25
Epigenetics Congress 2018
25 Oct 18
Istanbul
Latest News

Cloud-EHR Platform Practice Fusion To Explore Possible IPO in 2017

Northeastern Vermont Regional Hospital Implements Plexus Technology Group's Anesthesia

Cloud-based EHR platform Practice Fusion has reportedly hired JPMorgan Chase to explore an initial public offering (IPO) in 2017, according to a recent New York Times story. The San-Francisco-based EHR provider for doctors could attract between $1.1B to $1.5B valuation based on the company’s potential revenue projections next year.

“An I.P.O. could potentially be an outcome for Practice Fusion, but currently we continue our focus on commercializing our products, growing the business and serving our physician community,” a Practice Fusion spokeswoman wrote in an email to the Times, declining to comment further. JPMorgan declined to comment.

Last November, the company appointed Tom Langan, the former chief commercial officer at Symphony Health Solutions as its permanent CEO after serving as the interim, replacing Ryan Howard who assumed the position of Chairman of the Board.

 Practice Fusion’s reported revenue was $26.9 million in 2014 and was expected to reach $46.1M in 2015. The company added over 5,000 new active medical practices and dozens of life science partners last year, while realizing accelerated year-over-year revenue growth of more than 70%. 2016 revenue is expected to reach $70 million in 2016.  To date, the Practice Fusion has raised $149 million funding at a $635M valuation.